Efficacy of Oral Tablet Vaccine Compares Favorably to Market-Leading Fluzone® SOUTH SAN FRANCISCO, Calif. , Jan. 22, 2020 (GLOBE NEWSWIRE) -- Vaxart, Inc. (VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines administered by tablet rather than by injection, announced
